The present invention, colon cancer, liver cancer, hepatocellular carcinoma, testicular cancer, thyroid cancer, gastric cancer, gastrointestinal cancer, bladder cancer, pancreatic cancer, head and neck cancer, kidney cancer, liposarcoma, fibrosarcoma, pleural mesothelioma, melanoma, It relates to a human AMHRII binding agent for use in a method for preventing or treating a cancer selected from the group of cancers including sarcoma, brain cancer, bone cancer, breast cancer, prostate cancer and leukemia. [Selection diagram] None本発明は、結腸癌、肝臓癌、肝細胞癌、精巣癌、甲状腺癌、胃癌、胃腸癌、膀胱癌、膵癌、頭頸部癌、腎臓癌、脂肪肉腫、線維肉腫、胸膜中皮腫、メラノーマ、肉腫、脳癌、骨癌、乳癌、前立腺癌、及び白血病を含む癌の群から選択される癌を予防又は処置する為の方法で使用する為のヒトＡＭＨＲＩＩ結合性剤に関する。【選択図】なし
